Description
We hope to address the intricate challenges associated with identifying and treating hypermobility syndromes, a group of disorders characterized by excessive flexibility in the joints. This talk aims to shed light on the multifaceted nature of these conditions, focusing on the importance of accurate diagnosis, which often requires a thorough clinical assessment and an understanding of the various presentations of hypermobility. Additionally, it explores the latest advancements in management strategies, emphasizing a multidisciplinary approach that includes physical therapy, pain management, and patient education to improve quality of life. By demystifying the complexities of hypermobility syndromes, this discussion brings renewed hope to patients and healthcare providers alike, fostering better outcomes through enhanced awareness and targeted care.

Learning Objectives

• Learning Objective 1: Educate healthcare professionals and attendees about the various types and presentations of hypermobility syndromes, including their epidemiology and common clinical features.
• Learning Objective 2: Provide attendees with insights into the diagnostic challenges associated with hypermobility syndromes, including the latest criteria, guidelines, and the importance of differentiating these conditions from other disorders.
• Learning Objective 3: Highlight the significance of a multidisciplinary approach to managing hypermobility syndromes, emphasizing the roles of physical therapy, pain management, and patient education in improving patient outcomes.
• Learning Objective 4: Share the latest research findings, innovative treatments, and emerging therapies in the field of hypermobility syndromes, illustrating how these advancements can lead to better patient care and future developments.
• Learning Objective 5: Encourage healthcare providers to adopt a patient-centered approach by understanding the complexities of hypermobility syndromes, tailoring management strategies to individual patient needs, and empowering patients through education and support.

Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.  

Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.

Faculty
Session Director: Jennifer Hankenson, MD, FAAPMR: Disclosed no relevant financial relationships.      
Nathan Rudin, MD: Disclosed no relevant financial relationships.        
Neyha Cherin, DO: Disclosed no relevant financial relationships.    
Isabel S. Huang, MD: Independent contractor for Quantum Pain and Sports; and Physician Life Care Planning.

AAPM&R Medical Education Committee
John C. Cianca, MD: Ownership or partnership with Musculoskeletal Ultrasound Consultants, LLC.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
Rachel A. Brakke Holman, MD: Disclosed no relevant financial relationships.
Joseph E. Burris, MD: Serves on the Speakers Bureau for, and received clinical research grants from Allergan.
David S. Cheng, MD: Disclosed no relevant financial relationships.
Theresa A. Gillis, MD: Disclosed no relevant financial relationships.
Kevin N. Hakimi, MD: Disclosed no relevant financial relationships.
Matthew T. Haas, MD: Disclosed no relevant financial relationships.
R.Samuel Mayer, MD: Royalties from Demos Medical Publishing.
Ameet S. Nagpal, MD MS MEd: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Royalities from Demos Publishing; board member, American Board of Physical Medicine and Rehabilitation.
Sarah M. Smith, MD: Disclosed no relevant financial relationships.
Stephanie Tow, MD: Disclosed no relevant financial relationships.
Kevin R. VIncent, MD, PhD: Disclosed no relevant financial relationships.

AAPM&R CME Committee
Karen P. Barr, MD: Disclosed no relevant financial relationships.
Cherry C. Junn, MD: Disclosed no relevant financial relationships.
Sheryl R. Levin, MD: Disclosed no relevant financial relationships.
Kentaro Onishi, DO: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
Cynthia G. Pineda, MD: Disclosed no relevant financial relationships.
Patricia T. Tan, MD: Disclosed no relevant financial relationships.
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Kristin A. Wong, MD: Disclosed no relevant financial relationships.

No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.

FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.